Cabenuva ER 400 MG-600 MG susp 4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQS4H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,703
Award facts
- Contract value 100% obligated
- $10,703.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 400 MG-600 MG suspension (4ML) with a ceiling value of $10,703.00 under a firm fixed price contract. The award was issued on December 17, 2025, with an ultimate completion date of January 9, 2026. CABENUVA is a long-acting injectable antiretroviral medication used in HIV treatment, representing a specialized pharmaceutical product within the federal medical supply chain. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made through open competition with no set-aside designation.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates capability across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies. This particular delivery order supports the DLA's mission to supply pharmaceutical products to military healthcare programs globally, with the contracted medication intended for service members and beneficiaries requiring advanced HIV treatment options. The firm fixed pricing structure and compressed delivery timeline reflect the operational requirements of federal medical procurement logistics.
Quick answers
Who was awarded contract SPE2DR26FQS4H?
SPE2DR26FQS4H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FQS4H worth?
The government has obligated $10,703 on SPE2DR26FQS4H.
Is contract SPE2DR26FQS4H an order under another contract?
Yes. SPE2DR26FQS4H is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQS4H competed?
The extent of competition for SPE2DR26FQS4H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award